Divergent Clinical and Immunologic Outcomes Based on STK11 Co-Mutation Status in Resectable KRAS-mutant Lung Cancers Following Neoadjuvant Immune Checkpoint Blockade
Clinical cancer research an official journal of the American Association for Cancer Research(2025)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined